Biotech

Latest Articles

Kailera launches along with $400M series A, 4 Mandarin weight problems drugs

.Kailera Therapeutics has released in to the more and more busy being overweight space with a portfo...

Metsera teams up with Amneal to secure down GLP-1 supply

.Along with very early period 1 data today out in bush, metabolic disease outfit Metsera is actually...

Rivus posts data to back up muscle-sparing excessive weight medication cases

.Rivus Pharmaceuticals has unveiled the information behind its period 2 excessive weight gain in car...

BMS spends $110M to develop T-cell therapy treaty, aiding Best acquire time to advance prioritized pipeline

.Bristol Myers Squibb is actually spending Main Medication $110 thousand in advance to develop reage...

Generate increases one more $1B-plus Large Pharma collaboration

.Novartis has tattooed an offer possibly worth much more than $1 billion with Flagship-founded Gener...

Metsera GLP-1 records cut uncovers 7.5% fat loss at 36 times

.Recently debuted Metsera is actually unfolding some stage 1 record for its GLP-1 receptor agonist, ...

Flagship really hopes biotechs group to Mirai to increase genetic meds

.In the middle of the hereditary medications branches race, Flagship Pioneering is revealing a new b...

BioAge eyes $180M from IPO, personal positioning for being overweight trials

.BioAge Labs is looking at all around $180 thousand in preliminary proceeds from an IPO and also a p...

Merck's LAG-3 combination fails colorectal cancer cells stage 3 research

.A try through Merck &amp Co. to open the microsatellite stable (MSS) metastatic colon cancer market...

Spanish VC shuts $200M lifestyle sciences fund

.Spain-based Asabys Allies has finalized a fund of 180 thousand europeans ($ 200 thousand), loan tha...

BioAge brings in $198M from IPO as excessive weight biotech participates in Nasdaq

.BioAge Labs is actually bringing in nearly $200 million by means of its own Nasdaq IPO this morning...

Acadia takes BMS veterinarian aboard as CEO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...

Cassava spends $40M over allegedly deceiving Alzheimer's improve

.Cassava Sciences has actually accepted to spend $40 thousand to address an inspection into claims i...

Merck bags choices on Evaxion's AI-designed vaccination prospects

.Merck &amp Co. has actually grabbed alternatives on pair of Evaxion Biotech injection applicants, p...

Enanta's RSV antiviral crushes popular load in problem study

.Enanta Pharmaceuticals has linked its own breathing syncytial infection (RSV) antiviral to substant...

Biogen containers SAGE-324 partnership after crucial shake fall short

.Biogen has actually conducted the final rites to its collaboration with Sage Rehabs on SAGE-324, ju...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout ratings

.On the exact same time that some Parkinson's health condition medicines are actually being actually...

Arch finalizes $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Endeavor Allies is co...

Orion to make use of Aitia's 'electronic twins' to locate brand new cancer cells medications

.Finnish biotech Orion has spied possible in Aitia's "digital twin" tech to cultivate brand new canc...

Windtree's surprise med rears high blood pressure in most recent period 2 succeed

.While Windtree Therapies has actually had a hard time to grow the economic origins needed to endure...